Loss of Dystrophin is common in Uterine Leiomyosarcoma: a potential biomarker for clinical application. Vadasz B, Felicelli C, Feng Y, Yin P, et al. Hum Pathol 2022 Dec 19:S0046-8177(22)00289.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vadasz B, Felicelli C, Feng Y, Yin P, et al. Loss of Dystrophin is common in Uterine Leiomyosarcoma: a potential biomarker for clinical application. Hum Pathol 2022 Dec 19:S0046-8177(22)00289.
PMID: 36549601